| Bliss GVS Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506197 |
NSE Symbol : BLISSGVS |
P/E(TTM) : 54.66 |
|
ISIN Demat : INE416D01022 |
Div & Yield% : 0.20 |
EPS(TTM) : 9.24 |
|
Book Value(₹) : 108.73 |
Market Cap(₹Cr) : 5,365.85 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 729.81 | 667.20 | 605.46 | 598.34 | 636.36 |
| Other Income | 43.72 | 36.22 | 33.50 | 50.77 | 35.37 |
| Stock Adjustments | 25.62 | -6.63 | 6.36 | -21.24 | 8.90 |
| Total Income | 799.15 | 696.79 | 645.32 | 627.87 | 680.63 |
| EXPENDITURE : | |||||
| Raw Materials | 368.25 | 339.47 | 305.83 | 293.66 | 352.84 |
| Power and Fuel Cost | 12.95 | 9.76 | 8.81 | 5.80 | 7.09 |
| Other Manufacturing Expenses | 20.05 | 15.50 | 17.25 | 11.57 | 11.54 |
| Selling and Administration Expenses | 79.30 | 78.23 | 66.73 | 66.90 | 67.07 |
| Miscellaneous Expenses | 21.50 | 26.61 | 64.52 | 36.48 | 32.45 |
| Employee Benefit Expenses | 121.50 | 99.42 | 82.59 | 72.54 | 65.06 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 175.59 | 127.80 | 99.59 | 140.93 | 144.57 |
| Interest | 11.11 | 6.58 | 5.81 | 10.06 | 4.32 |
| Gross Profit | 164.48 | 121.22 | 93.78 | 130.87 | 140.25 |
| Depreciation | 31.02 | 27.05 | 23.52 | 15.17 | 13.85 |
| Profit Before Tax | 133.46 | 94.17 | 70.26 | 115.70 | 126.40 |
| Current Tax | 42.54 | 29.99 | 26.34 | 34.42 | 31.92 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.95 | -4.79 | -6.72 | -4.21 | 1.81 |
| Reported Net Profit | 96.87 | 68.97 | 50.64 | 85.48 | 92.66 |
| Extraordinary Items | -1.25 | -0.14 | -25.47 | 0.26 | 2.09 |
| Adjusted Net Profit | 98.12 | 69.11 | 76.11 | 85.22 | 90.57 |
| Adjustment below Net Profit | -0.18 | -0.56 | -0.15 | -0.67 | 0.30 |
| Profit/Loss Balance carried down | 956.86 | 892.57 | 846.18 | 765.33 | 676.22 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 9.91 | 4.12 | 4.10 | 3.97 | 3.86 |
| P & L Balance carried down | 1,043.65 | 956.86 | 892.57 | 846.18 | 765.33 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Dividend Per Share(Rs) | 0.10 | 0.50 | 0.50 | 0.50 | 0.50 |
| Earnings Per Share-Unit Curr | 9.16 | 6.55 | 4.84 | 8.21 | 8.94 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 109.20 | 100.47 | 94.41 | 89.96 | 82.12 |
| Book Value(Adj)-Unit Curr | 109.20 | 100.47 | 94.41 | 89.96 | 82.12 |
